MobiHealth News October 22, 2021
Laura Lovett

This news comes roughly a year after the company signed a $500 million deal with Boehringer Ingelheim.

This morning prescription digital therapeutic company Click Therapeutic announced a $52 million Series B funding round. H.I.G. BioHealth Partners and Accelmed Partners ll led the round, with participation from Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures and RdigetopHealth. 

This news comes over a year after the company inked a $500 million-plus deal with pharma company Boehringer Ingelheim to jointly commercialize a digital treatment for patients with schizophrenia. 


Click Therapeutic is focused on providing software as a prescription therapy for a number of conditions. The company got its start in smoking cessation, and quickly expanded to include other...

Today's Sponsors


Today's Sponsors


Today's Sponsor


Topics: Digital Health, Investments, Technology, Trends
The prestigious alumni of MedCity INVEST Pitch Perfect contest for healthcare startups
PCORI Invests $23.5M in Innovative mHealth, Telehealth Studies
Independence Health Group tops $60M investment in BCBS-partnered digital health firm
With Backing from Omega, SafelyYou Wraps $30M Funding Round
Quartet Health Lands New $60M of Funding, Plans to be in 30 States by End of 2022